Skip to main content
Equibles
LNAI logo

LNAI · Lunai Bioworks Inc. · Metrics

Track LNAI — free

Use LNAI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LNAI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.21 -0.07 (-2.86%)
Rebalance outlook locked
Going-concern doubt — flagged May 15, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the financial statements are issued.”
View the 10-Q filed May 15, 2026
Market Cap
$9.84M
Shares
4.53M

LNAI metrics

39 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.28
Market cap
$9.84M

Price action

20 metrics
Price change (1W)
-16.9%
Price change (30D)
+0.2%
Price change (3M)
-45.8%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
133.3%
Annualized volatility (3M)
128.0%
Beta
—
RSI (14D)
42.9
Price vs SMA 50
-9.9%
Price vs SMA 200
—
Avg volume (3M)
647,752
Relative volume
0.1
Average dollar volume
$2.31M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
4.53M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1,303.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$133.53M
Net income (TTM)
−$128.28M
Trailing 12 months
Diluted EPS (TTM)
$-61.12
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-96.28

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
-1,459.3%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+52.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-1,301.0%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
−$133.43M
Free cash flow (TTM)
—
Quick ratio
0.2
Interest coverage
-247.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.16M
Total assets
$9.86M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.26M
Capital expenditures (TTM)
—
R&D (TTM)
$56,434
SG&A (TTM)
—
Stock compensation (TTM)
$1.38M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
15
13F filer change QoQ
-13
Institutional ownership
3.5%

Short interest

3 metrics
Short interest
3.8%
Latest settlement · 5.8 days to cover
Days to cover
5.8d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1527728 CUSIP 29350E302 Visit website